GSK, mRNA
British drugmaker GSK moves mRNA flu vaccine to late-stage trials
(Reuters) -British drugmaker GSK announced on Thursday positive results from a mid-stage trial of its seasonal influenza vaccine programme using the messenger RNA (mRNA) technology, and said it would now progress to late-stage clinical development.
GSK Says mRNA Flu Shot Shows Promise in Boost for Pipeline
GSK Plc’s experimental mRNA flu vaccine showed a positive immune response against two key types of flu viruses in a mid-stage trial, keeping the drugmaker in the race to bring the technology to seasonal influenza shots.
GSK's mRNA flu vaccine finally overcomes tricky B strains in phase 2 trial
After an initial defeat against the biggest barrier to mRNA flu vaccines—namely, B strains of influenza—GSK has returned with a reformulated candidate that has
GSK, CureVac mRNA flu shot reaches late-stage studies
GSK (NYSE:GSK) on Thursday announced its decision to advance its messenger-RNA-based flu vaccine candidate developed with CureVac (NASDAQ:CVAC) into late-stage development following a positive Phase 2 readout. The British drugmaker said that the vaccine ...
GSK’s mRNA seasonal flu vaccine shows promise in younger and older adults
GSK has shared positive headline results for its mRNA seasonal influenza vaccine and outlined that it will now progress the programme into late-stage clinical development. The phase 2 NCT06431607 study has been evaluating different dose levels of a modified,
GSK’s mRNA Flu Vaccine Candidate Moves to Phase III After Positive Phase II Results
GSK has reported positive results from its phase II trial for an mRNA seasonal influenza vaccine candidate, showing strong immune responses again
British drugmaker GSK moves mRNA flu vaccine to late-stage trials
British drugmaker GSK (GSK.L), opens new tab announced on Thursday positive results from a mid-stage trial of its seasonal influenza vaccine programme using the messenger RNA (mRNA) technology ...
FDA approves ‘FluMist,' says no healthcare provider needed
FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...
Health Affairs2d
How Policy Makers Can Act Now To Prevent An Avian Influenza Pandemic
It is not inevitable that H5N1 will develop into a pandemic -- if we act now. Unfortunately, instead of urgent action, we ...
London South East10d
GSK reports positive results from mRNA flu vaccine trial
(Sharecast News) - GSK announced promising results from its phase two clinical trial for an mRNA-based seasonal flu vaccine on Thursday. The FTSE 100 pharmaceuticals giant said the study ...
US FDA approves AstraZeneca's self-administered nasal spray flu vaccine
The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's nasal spray flu vaccine for ...